I would suggest some objectivity may favour your investing style. Shows a lack of maturity.
I would not consider phase 1b trials statistically significant.
Just because you don't understand the statistical significance, does not mean my point(s) aren't valid.
Here are some readings for you.....
https://www.students4bestevidence.net/statistical-significance-vs-clinical-significance/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197528/
https://www.uws.edu/wp-content/uploads/2013/10/P_Values_Statistical_Sig_Clinical_Sig.pdf
https://jamanetwork.com/journals/jamadermatology/fullarticle/480877
Bot Chart, page-1794
-
- There are more pages in this discussion • 12,105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.005(1.33%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 39.0¢ | 37.0¢ | $1.603M | 4.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 378157 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 98000 | 5 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |